Complement alternate pathway AH50 actual/normal:RelACnc:Pt:Ser:Qn:IA

Preferred Label : Complement alternate pathway AH50 actual/normal:RelACnc:Pt:Ser:Qn:IA;

LOINC status : ACTIVE;

LOINC display name : Complement alternate pathway AH50 actual/normal IA (S) [Rel units/Vol];

LOINC long common name : Complement alternate pathway AH50 actual/normal in Serum by Immunoassay;

LOINC short name : AH50 Act/Nor Ser IA;

Details

Origin ID

74520-8;

UMLS CUI

C3847383;

Has component
- Complement [LOINC component]
- Complement alternate pathway AH50 [LOINC component]
- Complement alternate pathway AH50 actual/normal [LOINC component]
Has method
- Immunoassay [LOINC method]
Has property
- Relative Arbitrary Concentration [LOINC Property]
Has system
- Serum [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Complement activity panel:-:Pt:Ser/Plas:-: [LOINC code]
- Eculizumab Monitoring Panel:-:Pt:Ser/Plas:-: [LOINC code]
- Ravulizumab Monitoring Panel:-:Pt:Ser/Plas:-: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients